Search Filters
Specialties
Regenerative Medicine
Clear All
Search
Specialties
Regenerative Medicine
19 results found in 1ms
Who qualifies for ChondroFiller Liquid Cartilage injection
avatar
Miss Sophie Harris
26/7/2026
Who qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
Who qualifies for a ChondroFiller injection
avatar
Miss Sophie Harris
13/7/2026
Who qualifies for a ChondroFiller injection
ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.ChondroFiller targets ICRS Grade III–IV cartilage damage, where more than half the cartilage is lost or bone is exposed. Delivered as an ultrasound-guided outpatient injection, the collagen scaffold recruits the patient's own progenitor cells to initiate repair.
ChondroFiller Injection Specialists in the UK
avatar
Miss Sophie Harris
5/7/2026
ChondroFiller Injection Specialists in the UK
Across 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.Across 19,000+ treated cases worldwide, ChondroFiller has a complication rate of 0.06%; 70–85% of patients with focal cartilage defects achieve meaningful symptom relief over 3–5 years through a collagen scaffold that recruits the patient's own repair cells.
How long ChondroFiller results last
avatar
Miss Sophie Harris
4/7/2026
How long ChondroFiller results last
ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.ChondroFiller's collagen scaffold biodegrades within 6–24 months, yet provides lasting clinical benefit by recruiting the patient's own cells to form repair tissue; 70–85% of well-selected patients maintain meaningful symptom relief at three to five years.
What the ChondroFiller evidence actually shows
avatar
Miss Sophie Harris
24/6/2026
What the ChondroFiller evidence actually shows
ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
ChondroFiller injection recovery timeline
avatar
Miss Sophie Harris
18/6/2026
ChondroFiller injection recovery timeline
ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.ChondroFiller is an outpatient collagen scaffold injection that recruits the patient's own stem cells to repair cartilage; most people notice improvement within 6–12 weeks, though complete tissue replacement takes one to two years.
ChondroFiller success rates in practice
avatar
Miss Sophie Harris
5/6/2026
ChondroFiller success rates in practice
ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.
19 results found in 1ms